Comprehensive medication guide to Allopurinol including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$10 copay for generic on most plans; allopurinol is typically Tier 1 on commercial insurance and Medicare Part D formularies, with no prior authorization required for the generic formulation.
Estimated Cash Pricing
$8–$90 retail for a 30–90 day supply of generic allopurinol (100 mg–300 mg tablets); as low as $3–$15 with GoodRx or SingleCare coupons, and as little as $10–$35 for a full year via Cost Plus Drugs mail order.
Medfinder Findability Score
90/100
Summarize with AI
On this page
Allopurinol is a prescription medication belonging to the xanthine oxidase inhibitor (XOI) drug class. It is primarily used to lower uric acid levels in the blood and urine, making it the cornerstone treatment for chronic gout and hyperuricemia. It has been FDA-approved since 1966 and is sold under the brand names Zyloprim, Lopurin, and Aloprim (IV formulation).
Allopurinol is FDA-approved for three indications: preventing gout attacks in patients with chronic gout and hyperuricemia, preventing tumor lysis syndrome (hyperuricemia caused by cancer chemotherapy), and reducing recurrent calcium oxalate kidney stones in patients with elevated urinary uric acid. It is recommended as the preferred first-line urate-lowering therapy by the American College of Rheumatology (ACR) 2020 Gout Guidelines.
As a generic medication available since the 1980s and produced by multiple manufacturers, allopurinol is one of the most affordable chronic disease medications in the United States. It is available in 100 mg, 200 mg, and 300 mg oral tablets, as well as a 500 mg IV formulation. The WHO lists allopurinol on its list of essential medicines.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Allopurinol works by inhibiting xanthine oxidase, the enzyme responsible for the final steps of uric acid production in the body. After being metabolized in the liver to its active form — oxypurinol — it blocks xanthine oxidase from converting hypoxanthine to xanthine and xanthine to uric acid. This reduces the total amount of uric acid released into the bloodstream.
When blood uric acid levels fall below the saturation point of 6 mg/dL, uric acid crystals that have accumulated in joints and soft tissue over time begin to dissolve. Over months to years of consistent therapy, this crystal dissolution eliminates the source of gout attacks. Allopurinol does not treat acute gout flares — it has no anti-inflammatory properties — but over time it eliminates the condition that causes them.
Because allopurinol blocks xanthine oxidase — the same enzyme that metabolizes azathioprine and 6-mercaptopurine — it has a critical drug interaction with these immunosuppressants. When used together without dose reduction, azathioprine or 6-MP levels can rise to toxic levels. This interaction must always be considered before prescribing allopurinol.
100 mg — tablet
Starting dose for gout; also used for patients with CKD starting at 50 mg
200 mg — tablet
Less commonly stocked than 100 mg or 300 mg; often substituted with two 100 mg tablets
300 mg — tablet
Most commonly prescribed maintenance strength for gout in patients with normal kidney function
500 mg — IV powder for injection
Hospital use only; for tumor lysis syndrome prevention when oral route is unavailable
Allopurinol oral tablets are generally widely available and are not in national shortage as of 2026. The medication has a findability score of 90/100 — one of the highest among gout medications — reflecting its multiple generic manufacturers and consistent demand. Large chain pharmacies (Walmart, Costco, CVS, Walgreens) routinely stock 100 mg and 300 mg tablets.
Despite overall good availability, individual pharmacy stock-outs do occur. The 200 mg tablet strength is notably less commonly stocked than 100 mg or 300 mg. Rural patients may face more limited options. The intravenous formulation (Aloprim) has historically been subject to supply disruptions in hospital settings.
If you're having trouble locating allopurinol at your pharmacy, medfinder can help. medfinder calls pharmacies near you to check which ones can fill your prescription — you provide your medication and location, and results are texted directly to you.
Allopurinol is not a controlled substance, so any licensed prescriber can write a prescription. The vast majority of allopurinol prescriptions are written by primary care providers and internists, not specialists, reflecting how routinely manageable gout is in primary care settings.
Telehealth availability: Allopurinol can be prescribed via telehealth in all 50 states. Because it's not a controlled substance, no in-person visit is required before obtaining a prescription. Major telehealth platforms including Teladoc, MDLive, and Amazon Clinic regularly prescribe allopurinol for gout management.
No. Allopurinol is not a controlled substance and has no DEA scheduling. It has no potential for abuse, dependence, or misuse. This means allopurinol prescriptions are not subject to the restrictions that apply to controlled substances — they can be called in by phone, transmitted electronically, have unlimited refills at the prescriber's discretion, and can be prescribed via telehealth in all 50 states without in-person visit requirements.
Patients taking allopurinol for chronic gout typically receive a prescription for 90-day supplies with multiple refills. There are no state-by-state prescribing restrictions, no PDMP (Prescription Drug Monitoring Program) reporting requirements, and no quantity limits imposed by regulatory bodies. Insurance plans may impose quantity limits independently of DEA requirements, but these are uncommon for allopurinol.
The most commonly reported adverse effects (occurring in >1% of patients) include:
Know what you need? Skip the search.
Febuxostat (Uloric)
Another XOI; works by same mechanism; preferred for allopurinol intolerance or hypersensitivity; carries FDA boxed warning for increased cardiovascular death risk; easier to dose in CKD
Probenecid
Uricosuric agent; increases renal excretion of uric acid; alternative for patients with normal renal function who cannot use XOIs; requires twice-daily dosing; not for patients with kidney stones
Colchicine (Colcrys)
Anti-inflammatory for acute gout attacks and prophylaxis during ULT initiation; does not lower uric acid; commonly prescribed alongside allopurinol for first 3-6 months
Pegloticase (Krystexxa)
IV uricase enzyme for refractory chronic gout; last resort for patients failing all oral ULTs; given every 2 weeks; carries boxed warning for anaphylaxis and infusion reactions
Prefer Allopurinol? We can find it.
Azathioprine (Imuran)
majorAllopurinol inhibits XO-mediated metabolism of azathioprine, causing 3-4x drug level increase and risk of severe myelosuppression (agranulocytosis). Avoid combination or reduce azathioprine to 25-33% of normal dose with close CBC monitoring.
6-Mercaptopurine (Purixan)
majorSame mechanism as azathioprine interaction — XO inhibition causes toxic accumulation. Avoid or reduce 6-MP dose significantly with specialist oversight.
Capecitabine
majorAvoid concomitant use. Allopurinol may reduce capecitabine's conversion to its active antineoplastic form, reducing chemotherapy efficacy.
Pegloticase (Krystexxa)
majorDiscontinue allopurinol before and during pegloticase therapy. Concurrent use interferes with monitoring pegloticase efficacy and may increase infusion reaction risk.
Warfarin (Coumadin)
moderateAllopurinol inhibits warfarin metabolism, prolonging half-life and increasing anticoagulant effect. Monitor INR more frequently; warfarin dose reduction may be needed.
Thiazide diuretics (e.g., hydrochlorothiazide)
moderateThiazides reduce renal clearance of allopurinol/oxypurinol, increasing drug levels and hypersensitivity reaction risk. Monitor kidney function and watch for skin reactions.
ACE inhibitors (e.g., lisinopril, enalapril)
moderateCombination increases risk of severe hypersensitivity reactions including anaphylaxis and SJS. Monitor closely for any allergic symptoms.
Theophylline
moderateAllopurinol inhibits theophylline metabolism, increasing blood levels and risk of toxicity (nausea, rapid heart rate, seizures). Monitor theophylline levels.
Cyclosporine
moderateAllopurinol increases cyclosporine blood levels, risking nephrotoxicity. Monitor cyclosporine levels closely.
Ampicillin / Amoxicillin
minorCombination significantly increases incidence of skin rash. Use alternative antibiotic class when possible; stop allopurinol and evaluate if rash develops.
Allopurinol is one of medicine's great success stories: a 60-year-old medication that remains the first-line treatment for one of the most common forms of inflammatory arthritis, available generically at remarkably low cost, and effective for millions of patients worldwide. For the vast majority of gout patients who can tolerate it, allopurinol — taken consistently and titrated to a uric acid target of ≤6 mg/dL — can essentially eliminate gout attacks over time.
The key challenges with allopurinol are adherence (fewer than half of patients remain on it at 12 months), appropriate titration (many patients are started and left on subtherapeutic doses), and awareness of its serious but rare drug interactions and hypersensitivity risks — particularly in patients of Southeast Asian or African American descent who may carry the HLA-B*5801 allele.
If you've been prescribed allopurinol and are having trouble finding it at your pharmacy, medfinder can help you locate it quickly. medfinder calls pharmacies near you and texts you which ones can fill your prescription — no hold music, no wasted trips.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards